Literature DB >> 28677665

Reinforcing Effects of Binary Mixtures of Common Bath Salt Constituents: Studies with 3,4-Methylenedioxypyrovalerone (MDPV), 3,4-Methylenedioxymethcathinone (methylone), and Caffeine in Rats.

Brenda M Gannon1, Kayla I Galindo1, Melson P Mesmin1, Kenner C Rice2, Gregory T Collins1,3.   

Abstract

Bath salts use is associated with high rates of abuse, toxicity, and death. Bath salt preparations often contain mixtures of drugs including multiple synthetic cathinones (eg, 3,4-methylenedioxypyrovalerone (MDPV) or 3,4-methylenedioxymethcathinone (methylone)) or synthetic cathinones and caffeine; however, little is known about whether interactions among bath salt constituents contribute to the abuse-related effects of bath salts preparations. This study used male Sprague-Dawley rats responding under a progressive ratio schedule to quantify the reinforcing effectiveness of MDPV, methylone, and caffeine, administered alone and as binary mixtures (n=12 per mixture). Each mixture was evaluated at four ratios (10 : 1, 3 : 1, 1 : 1, and 1 : 3) relative to the mean ED50 for each drug alone. Dose-addition analyses were used to determine the predicted, additive effect for each dose pair within each drug mixture. MDPV, methylone, and caffeine maintained responding in a dose-dependent manner, with MDPV being the most potent and effective, and caffeine being the least potent and effective of the three bath salts constituents. High levels of responding were also maintained by each of the bath salts mixtures. Although the nature of the interactions tended toward additivity for most bath salts mixtures, supra-additive (3 : 1 MDPV : caffeine, and 3 : 1 and 1 : 1 methylone : caffeine) and sub-additive (3 : 1, 1 : 1, and 1 : 3 MDPV : methylone) interactions were also observed. Together, these findings demonstrate that the composition of bath salts preparations can have an impact on both their reinforcing potency and effectiveness, and suggest that such interactions among constituent drugs could contribute to the patterns of use and effects reported by human bath salts users.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28677665      PMCID: PMC5809783          DOI: 10.1038/npp.2017.141

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  42 in total

Review 1.  Mechanisms of the psychostimulant effects of caffeine: implications for substance use disorders.

Authors:  Sergi Ferré
Journal:  Psychopharmacology (Berl)       Date:  2016-01-20       Impact factor: 4.530

2.  Prediction of abuse liability of drugs using IV self-administration by rats.

Authors:  R J Collins; J R Weeks; M M Cooper; P I Good; R R Russell
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

3.  Self-administration of caffeine by the rat.

Authors:  J Atkinson; M Enslen
Journal:  Arzneimittelforschung       Date:  1976

Review 4.  The application of drug dose equivalence in the quantitative analysis of receptor occupation and drug combinations.

Authors:  Ronald J Tallarida; Robert B Raffa
Journal:  Pharmacol Ther       Date:  2010-05-28       Impact factor: 12.310

5.  Presence and composition of cathinone derivatives in drug samples taken from a drug test service in Spain (2010-2012).

Authors:  Fernando Caudevilla-Gálligo; Mireia Ventura; Blanca Iciar Indave Ruiz; Iván Fornís
Journal:  Hum Psychopharmacol       Date:  2013-07       Impact factor: 1.672

6.  Pharmacological characterization of designer cathinones in vitro.

Authors:  L D Simmler; T A Buser; M Donzelli; Y Schramm; L-H Dieu; J Huwyler; S Chaboz; M C Hoener; M E Liechti
Journal:  Br J Pharmacol       Date:  2013-01       Impact factor: 8.739

7.  Potent rewarding and reinforcing effects of the synthetic cathinone 3,4-methylenedioxypyrovalerone (MDPV).

Authors:  Lucas R Watterson; Peter R Kufahl; Natali E Nemirovsky; Kaveish Sewalia; Megan Grabenauer; Brian F Thomas; Julie A Marusich; Scott Wegner; M Foster Olive
Journal:  Addict Biol       Date:  2012-07-11       Impact factor: 4.280

8.  Analysis of first and second generation legal highs for synthetic cannabinoids and synthetic stimulants by ultra-performance liquid chromatography and time of flight mass spectrometry.

Authors:  Kevin G Shanks; Tim Dahn; George Behonick; Andrea Terrell
Journal:  J Anal Toxicol       Date:  2012-05-14       Impact factor: 3.367

9.  Rapid nondestructive on-site screening of methylamphetamine seizures by attenuated total reflection fourier transform infrared spectroscopy.

Authors:  Ching Yong Goh; Wilhelm van Bronswijk; Colin Priddis
Journal:  Appl Spectrosc       Date:  2008-06       Impact factor: 2.388

10.  The Reinforcing and Rewarding Effects of Methylone, a Synthetic Cathinone Commonly Found in "Bath Salts"

Authors:  Lucas R Watterson; Lauren Hood; Kaveish Sewalia; Seven E Tomek; Stephanie Yahn; Craig Trevor Johnson; Scott Wegner; Bruce E Blough; Julie A Marusich; M Foster Olive
Journal:  J Addict Res Ther       Date:  2012-12-01
View more
  18 in total

1.  Effects of lorcaserin and buspirone, administered alone and as a mixture, on cocaine self-administration in male and female rhesus monkeys.

Authors:  Gregory T Collins; Charles P France
Journal:  Exp Clin Psychopharmacol       Date:  2018-06-28       Impact factor: 3.157

2.  Behavioral economic analysis of the reinforcing effects of "bath salts" mixtures: studies with MDPV, methylone, and caffeine in male Sprague-Dawley rats.

Authors:  Brenda M Gannon; Melson P Mesmin; Agnieszka Sulima; Kenner C Rice; Gregory T Collins
Journal:  Psychopharmacology (Berl)       Date:  2018-09-29       Impact factor: 4.530

3.  Relative reinforcing effects of second-generation synthetic cathinones: Acquisition of self-administration and fixed ratio dose-response curves in rats.

Authors:  Brenda M Gannon; Kayla I Galindo; Melson P Mesmin; Agnieszka Sulima; Kenner C Rice; Gregory T Collins
Journal:  Neuropharmacology       Date:  2017-08-12       Impact factor: 5.250

4.  The synthetic cathinone psychostimulant α-PPP antagonizes serotonin 5-HT2A receptors: In vitro and in vivo evidence.

Authors:  Yiming Chen; Bruce E Blough; Kevin S Murnane; Clinton E Canal
Journal:  Drug Test Anal       Date:  2019-04-22       Impact factor: 3.345

5.  Effects of cocaine on the discriminative stimulus and reinforcing effects of mephedrone in male rats.

Authors:  Laura L Erwin; Mark R Nilges; Zachary B Bondy; Peter J Winsauer
Journal:  Psychopharmacology (Berl)       Date:  2018-11-17       Impact factor: 4.530

6.  Self-administration of the synthetic cathinones 3,4-methylenedioxypyrovalerone (MDPV) and α-pyrrolidinopentiophenone (α-PVP) in rhesus monkeys.

Authors:  Gregory T Collins; Agnieszka Sulima; Kenner C Rice; Charles P France
Journal:  Psychopharmacology (Berl)       Date:  2019-07-26       Impact factor: 4.530

7.  "Ecstasy" to addiction: Mechanisms and reinforcing effects of three synthetic cathinone analogs of MDMA.

Authors:  Sean B Dolan; Zhenglan Chen; Renqi Huang; Michael B Gatch
Journal:  Neuropharmacology       Date:  2018-01-31       Impact factor: 5.250

8.  Role of monoaminergic systems and ambient temperature in bath salts constituent 3,4-methylenedioxypyrovalerone (MDPV)-elicited hyperthermia and locomotor stimulation in mice.

Authors:  Brenda M Gannon; Adrian Williamson; Kenner C Rice; William E Fantegrossi
Journal:  Neuropharmacology       Date:  2017-09-05       Impact factor: 5.250

9.  The abuse-related effects of pyrrolidine-containing cathinones are related to their potency and selectivity to inhibit the dopamine transporter.

Authors:  Brenda M Gannon; Michael H Baumann; Donna Walther; Cristian Jimenez-Morigosa; Agnieszka Sulima; Kenner C Rice; Gregory T Collins
Journal:  Neuropsychopharmacology       Date:  2018-09-10       Impact factor: 7.853

10.  Interactions between reinforcement history and drug-primed reinstatement: Studies with MDPV and mixtures of MDPV and caffeine.

Authors:  Michelle R Doyle; Agnieszka Sulima; Kenner C Rice; Gregory T Collins
Journal:  Addict Biol       Date:  2020-04-01       Impact factor: 4.280

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.